Infusion therapy business coming to Binghamton's Southside
BINGHAMTON, N.Y. (WIVT/WBGH) – A new infusion therapy business is moving into the former cost cutters on Pennsylvania Ave on Binghamton's Southside.
The business is called Vivo Infusion, based out of Colorado, and offers infusions, which is a way to take your medication directly to your bloodstream from an IV or injection.
On its website, the business lists some of the conditions that can be treated via infusion, autoimmune disorders such as Rheumatoid Arthritis, infectious diseases, chronic pain, and many more.
The website says the Penn Ave location is coming soon and will be open Monday through Saturday from 8 to 6 and Sundays by appointment only.
Find out more online at VivoInfusion.com.
Port Dickinson Elementary School recognized for student achievement
Infusion therapy business coming to Binghamton's Southside
Federal cuts expected to affect local agriculture programs
Remarkable Women: Ann Marie Bogart
'Bring it on': Riley to NRCC on Democrat target list
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
43 minutes ago
- Medscape
CVD Mortality Higher in Women With Inflammatory Diseases
Although cardiovascular disease (CVD)-related mortality decreased significantly from 1999 to 2020 in both men and women with immune-mediated inflammatory diseases (IMIDs), women consistently had higher rates of CVD-related mortality than men over the 22-year period. METHODOLOGY: Researchers analyzed CDC Multiple Cause of Death files from 1999 to 2020 to assess the sex differences in CVD-related mortality in patients with IMIDs. They identified CVD-related deaths with underlying IMIDs in the United States using diagnostic codes. IMIDs such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis were analyzed. The analysis included 281,355 IMID-related deaths and 127,149 CVD-related deaths over a period of 22 years. Annual crude and adjusted death rates were estimated. TAKEAWAY: Age-adjusted CVD-related mortality for women with IMIDs declined from 3.3 per 100,000 in 1999 to 1.4 per 100,000 in 2020, whereas the rate in men with IMIDs declined from 2.3 to 1.1 per 100,000 ( P < .01). < .01). However, women had higher mortality than men throughout the study duration (mortality rate ratio, 1.5; P < .01). < .01). Cerebrovascular disease and ischemic heart disease were major causes of death, with women more affected than men; women experienced mortality from arrhythmia and cardiac arrest at more than twice the rate of men. Among patients with IMIDs, women with rheumatoid arthritis had disproportionately higher crude CVD-related mortality than men with rheumatoid arthritis. IN PRACTICE: 'Addressing these risks requires increasing awareness of atypical cardiovascular symptoms in females with IMIDs, enhancing early detection through advanced imaging, and ensuring equitable access to therapies like biologics,' the study authors wrote. SOURCE: This study was led by Issam Motairek, MD, Cleveland Clinic, Cleveland. It was published online on May 5, 2025, in Circulation: Cardiovascular Quality and Outcomes . LIMITATIONS: The potential inaccuracies in the codes for identifying the cause of death may have misclassified IMIDs or CVD-related causes. The aggregate data structure prevented the analyses of individual-level factors such as severity of disease or treatments. Less common IMIDs were excluded, which may have underestimated their contribution to CVD. DISCLOSURES: This study received no specific funding. The authors reported having no conflicts of interest.
an hour ago
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
ALBANY, N.Y. -- Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation. The New York Senate gave final approval to the bill Monday night after hours of debate during which supporters said it would let terminally ill people die on their own terms. 'It's not about hastening death, but ending suffering,' said state Sen. Brad Hoylman-Sigal, a Democrat who sponsored the proposal. Opponents have argued the state should instead improve end-of-life medical care or have objected on religious grounds. 'We should not be in the business of state-authorized suicide,' said state Sen. George Borrello, a Republican. The state Assembly passed the measure in late April. The proposal requires that a terminally ill person who is expected to die within six month make a written request for the drugs. Two witnesses would have sign the request to ensure that the patient is not being coerced. The request would then have to be approved by the person's attending physician as well as a consulting physician. The legislation was first introduced in 2016, Hoylman-Sigal said, though it has stalled year after year in the New York statehouse. Dennis Poust, executive director of the New York State Catholic Conference, which has opposed the measure, said 'This is a dark day for New York State." Eleven other states and Washington, D.C., have laws allowing medically assisted suicide, according to Compassion & Choices, an advocacy organization that backs the policy. Corinne Carey, the group's local campaign director, said lawmakers had 'recognized how important it is to give terminally ill New Yorkers the autonomy they deserve over their own end-of-life experiences.' 'The option of medical aid in dying provides comfort, allowing those who are dying to live their time more fully and peacefully until the end,' said Carey.
San Francisco Chronicle
5 hours ago
- San Francisco Chronicle
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
ALBANY, N.Y. (AP) — Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation. The New York Senate gave final approval to the bill Monday night after hours of debate during which supporters said it would let terminally ill people die on their own terms. 'It's not about hastening death, but ending suffering,' said state Sen. Brad Hoylman-Sigal, a Democrat who sponsored the proposal. Opponents have argued the state should instead improve end-of-life medical care or have objected on religious grounds. 'We should not be in the business of state-authorized suicide,' said state Sen. George Borrello, a Republican. The state Assembly passed the measure in late April. The proposal requires that a terminally ill person who is expected to die within six month make a written request for the drugs. Two witnesses would have sign the request to ensure that the patient is not being coerced. The request would then have to be approved by the person's attending physician as well as a consulting physician. The legislation was first introduced in 2016, Hoylman-Sigal said, though it has stalled year after year in the New York statehouse. Dennis Poust, executive director of the New York State Catholic Conference, which has opposed the measure, said 'This is a dark day for New York State." Eleven other states and Washington, D.C., have laws allowing medically assisted suicide, according to Compassion & Choices, an advocacy organization that backs the policy. Corinne Carey, the group's local campaign director, said lawmakers had 'recognized how important it is to give terminally ill New Yorkers the autonomy they deserve over their own end-of-life experiences.'
